Genenta Science Overview
- Year Founded
-
2014

- Status
-
Public
- Employees
-
13

- Stock Symbol
-
K5F

- Share Price
-
$4.15
- (As of Tuesday Closing)
Genenta Science General Information
Description
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Contact Information
Website
www.genenta.comCorporate Office
- Dibit-San Raffaele Hospital
- Via Olgettina 58
- 20132 Milan
- Italy
Corporate Office
- Dibit-San Raffaele Hospital
- Via Olgettina 58
- 20132 Milan
- Italy
Genenta Science Timeline
Genenta Science Stock Performance
As of 13-May-2025, Genenta Science’s stock price is $4.15. Its current market cap is $81.4M with 18.3M shares.
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$4.15 | $4.18 | $2.78 - $6.94 | $81.4M | 18.3M | -$0.53 |
Genenta Science Financials Summary
As of 31-Dec-2024, Genenta Science has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 61,439 | 61,439 | 66,035 | 63,975 |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (9,684) | (9,684) | (12,890) | (8,946) |
Net Income | (9,644) | (9,644) | (12,601) | (8,914) |
Total Assets | 15,425 | 15,425 | 24,703 | 35,859 |
Total Debt | 0 | 0 | 0 | 0 |
Genenta Science Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Genenta Science Comparisons
Industry
Financing
Details
Genenta Science Competitors (6)
One of Genenta Science’s 6 competitors is Mustang Bio, a Formerly VC-backed company based in Waltham, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Mustang Bio | Formerly VC-backed | Waltham, MA | ||||
Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
Allogene Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
Bluebird Bio | Formerly VC-backed | Somerville, MA | ||||
Cellectis | Formerly VC-backed | Paris, France |
Genenta Science Signals
Genenta Science Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Genenta Science FAQs
-
When was Genenta Science founded?
Genenta Science was founded in 2014.
-
Where is Genenta Science headquartered?
Genenta Science is headquartered in Milan, Italy.
-
What is the size of Genenta Science?
Genenta Science has 13 total employees.
-
What industry is Genenta Science in?
Genenta Science’s primary industry is Biotechnology.
-
Is Genenta Science a private or public company?
Genenta Science is a Public company.
-
What is Genenta Science’s stock symbol?
The ticker symbol for Genenta Science is K5F.
-
What is the current stock price of Genenta Science?
As of 13-May-2025 the stock price of Genenta Science is $4.15.
-
What is the current market cap of Genenta Science?
The current market capitalization of Genenta Science is $81.4M.
-
Who are Genenta Science’s competitors?
Mustang Bio, Sangamo Therapeutics, Allogene Therapeutics, Bluebird Bio, and Cellectis are some of the 6 competitors of Genenta Science.
-
What is Genenta Science’s annual earnings per share (EPS)?
Genenta Science’s EPS for 12 months was -$0.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »